Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Astellas Confident of Hitting 3-Year Biz Goals on Xtandi, Full Backing of New Products
Astellas Pharma President and CEO Kenji Yasukawa expressed his confidence on May 18 that the company will be able to achieve the goals of its ongoing three-year business plan through March 2021 thanks to Xtandi’s (enzalutamide) ongoing momentum and full…
To read the full story
BUSINESS
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026





